Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children

• Status: Completed
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo in reducing the incidence and severity of ED in a pediatric neurosurgical population.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: St. Luke's-Roosevelt Hospital Center
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• Children age 6 months through 17 years of age undergoing interventional neuroradiologic procedures at our hospital under general anesthesia

• Patients classify as an ASA (American Society of Anesthesiologists) I-III

• Have not received anesthetic for over 30 days from previous procedures

Exclusion Criteria:

• Receiving digoxin therapy from the study

• Severe congestive heart failure or pulmonary hypertension requiring vasodilators

• Disease processes other than that associated with their intracranial pathology, such as hepatic or renal dysfunction